GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chordia Therapeutics Inc (TSE:190A) » Definitions » Other Long Term Assets

Chordia Therapeutics (TSE:190A) Other Long Term Assets : 円23.59 Mil (As of Aug. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Chordia Therapeutics Other Long Term Assets?

Chordia Therapeutics's other long-term assets for the quarter that ended in Aug. 2024 was 円23.59 Mil.

Chordia Therapeutics's quarterly other long-term assets increased from Aug. 2022 (円4.66 Mil) to Aug. 2023 (円10.59 Mil) and increased from Aug. 2023 (円10.59 Mil) to Aug. 2024 (円23.59 Mil).

Chordia Therapeutics's annual other long-term assets increased from Aug. 2022 (円4.66 Mil) to Aug. 2023 (円10.59 Mil) and increased from Aug. 2023 (円10.59 Mil) to Aug. 2024 (円23.59 Mil).


Chordia Therapeutics Other Long Term Assets Historical Data

The historical data trend for Chordia Therapeutics's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chordia Therapeutics Other Long Term Assets Chart

Chordia Therapeutics Annual Data
Trend Aug21 Aug22 Aug23 Aug24
Other Long Term Assets
4.97 4.66 10.59 23.59

Chordia Therapeutics Semi-Annual Data
Aug21 Aug22 Aug23 Aug24
Other Long Term Assets 4.97 4.66 10.59 23.59

Chordia Therapeutics Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.


Chordia Therapeutics Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
2-26-1 Muraoka-Higashi, Kanagawa, Fujisawa, JPN, 251-0012
Chordia Therapeutics Inc is a bio-venture company specializing in cancer research and development. Its mission is to deliver first-in-class cancer drugs to patients. It is a clinical-stage biotech company engaged in researching and developing novel therapies for cancers with high unmet medical needs.

Chordia Therapeutics Headlines

No Headlines